Skip to Content

Raia Drogasil SA ADR RADLY

Morningstar Rating
$6.50 +0.87 (15.36%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

RADLY is trading within a range we consider fairly valued.
Price
$6.50
Fair Value
$9.90
Uncertainty
Medium
1-Star Price
$4.78
5-Star Price
$2.83
Economic Moat
Ycfsmv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RADLY is a good fit for your portfolio.

Trading Information

Previous Close Price
$5.63
Day Range
$6.506.50
52-Week Range
$4.008.25
Bid/Ask
$4.81 / $6.50
Market Cap
$11.13 Bil
Volume/Avg
383 / 2,283

Key Statistics

Price/Earnings (Normalized)
52.17
Price/Sales
1.75
Dividend Yield (Trailing)
0.66%
Dividend Yield (Forward)
0.66%
Total Yield
0.66%

Company Profile

Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.
Sector
Healthcare
Industry
Pharmaceutical Retailers
Stock Style Box
Large Growth
Total Number of Employees
55,219

Comparables

Valuation

Metric
RADLY
PGMN3
HYPE3
Price/Earnings (Normalized)
52.1729.9311.37
Price/Book Value
9.800.631.83
Price/Sales
1.750.132.54
Price/Cash Flow
23.185.1212.33
Price/Earnings
RADLY
PGMN3
HYPE3

Financial Strength

Metric
RADLY
PGMN3
HYPE3
Quick Ratio
0.510.441.31
Current Ratio
1.471.481.89
Interest Coverage
2.870.502.37
Quick Ratio
RADLY
PGMN3
HYPE3

Profitability

Metric
RADLY
PGMN3
HYPE3
Return on Assets (Normalized)
5.94%−0.31%7.98%
Return on Equity (Normalized)
19.53%−1.07%17.15%
Return on Invested Capital (Normalized)
13.97%4.82%12.77%
Return on Assets
RADLY
PGMN3
HYPE3
See how this stock stacks up to its competitors with Morningstar Investor

Pharmaceutical Retailers Industry Comparables

Sponsor Center